CDC Recommendations for Flu Treatment and Prophylaxis
CDC recommends neuraminidase inhibitors
According to the Centers for Disease Control (CDC), neuraminidase inhibitors are:
- Recommended for the treatment and prophylaxis of influenza2
- Effective against both influenza type A and B2
CDC continues to recommend neuraminidase inhibitors
- Since the 2004-2005 flu season, neuraminidase inhibitors have been recommended each year2
- Over the same period, CDC has not recommended use of older antivirals (M2 Inhibitors) due to high resistance potential2
CDC recommends neuraminidase inhibitors for treatment and prevention of influenza
type A and B.
Next topic: Neuraminidase Inhibitors